Study Evaluating the Safety and Efficacy of C-CHOP in Untreated Subjects With Angioimmunoblastic T Cell Lymphoma
Clinical trial NCT03853044 · UNKNOWN
Trial details
- NCT number
- NCT03853044
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-29
- Primary completion
- 2021-06-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.